Yuko Honda
Mitaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: October 06, 2025
Outcomes of patients with in-hospital stroke with and without active cancer.
Journal: Journal of thrombosis and thrombolysis
Published: May 16, 2025
Cilostazol was effective for capsular warning syndrome during anticoagulant therapy: a case report
Journal: Rinsho shinkeigaku = Clinical neurology
Published: February 18, 2024
Dynamic 3D CT Angiography can Detect Swallowing and Head-Rotation-Induced Location Inversion Between the Carotid Artery and Hyoid Bone in Asymptomatic Carotid Artery Stenosis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: October 17, 2023
Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study.
Journal: Annals of neurology
Published: April 14, 2023
Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2.
Journal: Journal of the American Heart Association
Published: March 07, 2022
Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: February 09, 2021
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats.
Journal: Journal of thrombosis and thrombolysis
Published: January 10, 2021
Improving Acute In-Hospital Stroke Care by Reorganization of an In-Hospital Stroke Code Protocol.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: September 20, 2020
Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
Journal: Journal of thrombosis and thrombolysis
Published: August 10, 2019
A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Journal: Journal of thrombosis and thrombolysis
Published: April 12, 2019
Last Updated: 09/26/2026